Article
Thiol drugs decrease SARS-CoV-2 lung injury <i>in vivo</i> and disrupt SARS-CoV-2 spike complex binding to ACE2 <i>in vitro</i>
2020-12-08
Abstract excerpt
Neutrophil-induced oxidative stress is a mechanism of lung injury in COVID-19, and drugs with a functional thiol group (“thiol drugs”), especially cysteamine, have anti-oxidant and anti-inflammatory properties that could limit this injury. Thiol drugs may also alter the redox status of the cysteine-rich SARS-CoV-2 spike glycoprotein (SARS-2-S) and thereby disrupt ACE2 binding. Using ACE2 binding assay, reporter vi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8a3c2dc2-e948-56ae-b303-ab61ecdb6570
- DOI
- 10.1101/2020.12.08.415505
